Pharmacokinetics of oral rosiglitazone in Taiwanese and post hoc comparisons with Caucasian, Japanese, Korean, and mainland Chinese subjects.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques

Volumn 10, Issue 4, 2007, Pages 411-419

  Chu, Kai Min ^a   Hu, Oliver Yoa Pu ^a   Pao, Li Heng ^a   Hsiong, Cheng Huei ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ROSIGLITAZONE;

ADULT; ARTICLE; ASIAN; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; GENETICS; HALF LIFE TIME; HUMAN; KOREA; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; TAIWAN;

ADMINISTRATION, ORAL; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CROSS-OVER STUDIES; HALF-LIFE; HUMANS; KOREA; MALE; MIDDLE AGED; TAIWAN; THIAZOLIDINEDIONES;

EID: 44849113881     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3159d     Document Type: Article

References (0)